title: The effects of age and ganglioside composition on the rate of motor nerve terminal regeneration following antibody-mediated injury in mice.
abstract: Gangliosides are glycosphingolipids highly enriched in neural plasma membranes, where they mediate a diverse range of functions and can act as targets for auto-antibodies present in human immune-mediated neuropathy sera. The ensuing autoimmune injury results in axonal and motor nerve terminal (mNT) degeneration. Both aging and ganglioside-deficiency have been linked to impaired axonal regeneration. To assess the effects of age and ganglioside expression on mNT regeneration in an autoimmune injury paradigm, anti-ganglioside antibodies and complement were applied to young adult and aged mice wildtype (WT) mice, mice deficient in either b- and c-series (GD3sKO) or mice deficient in all complex gangliosides (GM2sKO). The extent of mNT injury and regeneration was assessed immediately or after 5 days, respectively. Depending on ganglioside expression and antibody-specificity, either a selective mNT injury or a combined injury of mNTs and neuromuscular glial cells was elicited. Immediately after induction of the injury, between 1.5% and 11.8% of neuromuscular junctions (NMJs) in the young adult groups exhibited healthy mNTs. Five days later, most NMJs, regardless of age and strain, had recovered their mNTs. No significant differences could be observed between young and aged WT and GM2sKO mice; aged GD3sKO showed a mildly impaired rate of mNT regeneration when compared with their younger counterparts. Comparable rates were observed between all strains in the young and the aged mice. In summary, the rate of mNT regeneration following anti-ganglioside antibody and complement-mediated injury does not differ majorly between young adult and aged mice irrespective of the expression of particular gangliosides.
authors: Neuroimmunology Group, Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, Glasgow Biomedical Research Centre, University of Glasgow, Glasgow, G12 8TA, United Kingdom.
authors: Angie
authors: A
authors: Rupp
authors: Madeleine E
authors: ME
authors: Cunningham
authors: Denggao
authors: D
authors: Yao
authors: Koichi
authors: K
authors: Furukawa
authors: Hugh J
authors: HJ
authors: Willison
mesh_terms: D000367:Age Factors; D000818:Animals; D001323:Autoantibodies / Q000276:immunology*; D020274:Autoimmune Diseases of the Nervous System / Q000276:immunology*; D003165:Complement System Proteins / Q000276:immunology; D005678:G(M2) Ganglioside / Q000276:immunology / Q000378:metabolism*; D005732:Gangliosides / Q000276:immunology / Q000378:metabolism*; D051379:Mice; D018345:Mice, Knockout; D017350:N-Acetylgalactosaminyltransferases / Q000235:genetics / Q000378:metabolism; D009416:Nerve Regeneration / Q000276:immunology*; D009469:Neuromuscular Junction / Q000276:immunology* / Q000503:physiopathology; D012583:Schwann Cells / Q000378:metabolism / Q000502:physiology; D012799:Sialyltransferases / Q000235:genetics / Q000378:metabolism
chemical_list: D001323:Autoantibodies; D005732:Gangliosides; D005678:G(M2) Ganglioside; C026226:ganglioside, GD3; D003165:Complement System Proteins; D017350:N-Acetylgalactosaminyltransferases; C023220:(N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase; D012799:Sialyltransferases; C043662:alpha-N-acetylneuraminate alpha-2,8-sialyltransferase
references: J Neurol Neurosurg Psychiatry. 2012 Jul;83(7):711-8
references: 22566597
references: Int J Dev Neurosci. 1990;8(6):667-78
references: 2288242
references: Ann Neurol. 2004 Aug;56(2):228-39
references: 15293275
references: J Neurochem. 1971 Oct;18(10):1821-9
references: 5118336
references: J Clin Invest. 1999 Sep;104(6):697-708
references: 10491405
references: Brain. 2010 Jul;133(Pt 7):1944-60
references: 20513658
references: J Biol Chem. 2001 Mar 9;276(10):6885-8
references: 11133999
references: Lancet Neurol. 2007 Jul;6(7):589-94
references: 17537676
references: Brain Res. 1995 Oct 23;696(1-2):76-82
references: 8574688
references: Neuron. 2000 Oct;28(1):41-51
references: 11086982
references: J Neurosci. 2005 Feb 16;25(7):1620-8
references: 15716397
references: N Engl J Med. 2012 Jun 14;366(24):2294-304
references: 22694000
references: J Neurosci. 2004 Dec 8;24(49):10999-1009
references: 15590915
references: Brain. 2003 Oct;126(Pt 10):2220-34
references: 12876146
references: Lancet Neurol. 2006 Dec;5(12):1021-8
references: 17110282
references: Brain. 2001 May;124(Pt 5):893-906
references: 11335692
references: J Neurochem. 2002 May;81(4):696-707
references: 12065629
references: Am J Physiol. 1992 Jun;262(6 Pt 1):C1341-55
references: 1616002
references: Neuroscience. 2005;135(4):1167-78
references: 16165298
references: Brain Res. 1986 Apr 30;372(1):163-6
references: 3708353
references: J Neurochem. 1963 Sep;10:613-23
references: 14066623
references: J Oleo Sci. 2011;60(10):537-44
references: 21937853
references: Proc Natl Acad Sci U S A. 1996 Oct 1;93(20):10662-7
references: 8855236
references: Ann Neurol. 2005 Aug;58(2):203-10
references: 16049921
references: Trends Neurosci. 1996 Jul;19(7):280-5
references: 8799973
references: J Clin Invest. 1999 Feb;103(4):497-505
references: 10021458
references: J Neurochem. 1985 Apr;44(4):1259-65
references: 3919160
references: Exp Neurol. 2012 Feb;233(2):836-48
references: 22197826
references: Glycobiology. 2001 Feb;11(2):125-30
references: 11287399
references: Neurobiol Aging. 2011 Jan;32(1):157-67
references: 19233512
references: Glia. 2007 May;55(7):746-57
references: 17352383
references: Neurology. 2002 Feb 26;58(4):610-4
references: 11865140
references: J Biol Chem. 2002 Jan 18;277(3):1633-6
references: 11682464
references: Neuroscience. 2008 Oct 28;156(4):885-97
references: 18801416
references: Exp Neurol. 2000 Dec;166(2):227-34
references: 11085888
references: Neurology. 2011 Mar 15;76(11):968-75
references: 21403108
references: Acta Neuropathol. 1968 Jan 2;10(1):26-33
references: 5640115
references: J Neurosci. 2007 Jan 3;27(1):27-34
references: 17202469
references: J Neurocytol. 1992 Jan;21(1):50-66
references: 1346630
references: Exp Neurol. 1980 Oct;70(1):65-82
references: 7418774
references: Neuron. 1995 Jan;14(1):125-32
references: 7826630
references: J Physiol. 2009 Aug 15;587(Pt 16):3979-99
references: 19564393
references: Glycobiology. 2008 Jul;18(7):509-16
references: 18480155
references: Ann Neurol. 2005 Mar;57(3):396-407
references: 15732093
references: Glia. 2005 Nov 15;52(3):177-89
references: 15968629
references: J Neurosci. 1998 Nov 15;18(22):9376-85
references: 9801376